Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 19Fibrosarcoma 8Leiomyosarcoma 7Sarcoma, Synovial 6Rhabdomyosarcoma 6Neurofibrosarcoma 6Lymphoma 6Liposarcoma 6Histiocytoma, Malignant Fibrous 6Hemangiosarcoma 6Osteosarcoma 5Neuroectodermal Tumors, Primitive, Peripheral 5Malignant mesenchymal tumor 5Hemangiopericytoma, Malignant 5Burkitt Lymphoma 4Testicular Neoplasms 3Teratoma 3Sarcoma, Ewing 3Sarcoma, Alveolar Soft Part 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Ovarian Neoplasms 3Lymphoma, Large B-Cell, Diffuse 3Hodgkin Disease 3Carcinoma, Embryonal 3Wilms Tumor 2Sarcoma, Endometrial Stromal 2Pheochromocytoma 2Neuroblastoma 2Neoplasm Metastasis 2Leukemia 2

Interventions

Vincristine 1Topotecan 1Razoxane 1Ifosfamide 1Etoposide 1Doxorubicin 1Dexrazoxane 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Localized Extraskeletal Ewing Sarcoma × Ifosfamide × Clear all
NCT01231906 2026-01-23

Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma

Children's Oncology Group

Phase 3 Completed
642 enrolled 11 charts
Sarcoma

Localized Extraskeletal Ewing Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡